A study assessed the efficacy of a treatment combination in the second-line treatment of metastatic colorectal cancer. The combination of pembrolizumab and lenvatinib did not improve survival in metastatic CRC. A systematic review reported that immune checkpoint inhibitor therapy shows promising results in metastatic CRC. The FRESCO-2 study showed that fruquintinib resulted in an overall survival benefit in metastatic colorectal cancer. Dr. Eng discusses the phase 3 FRESCO-2 study and how fruquintinib fits in with current treatments for advanced CRC. The rate of colorectal cancer (CRC) screenings decreased by more than 20% during the COVID-19 pandemic. Pranob Bhattacharya discusses zolbetuximab, a first-in-class investigational therapy for the treatment of gastric cancer. The Oncology Brothers speak with Cathy Eng, MD, about treatment of metastatic colorectal cancer with fruquintinib. Results from a recent study suggest a novel therapy that may effectively treat pancreatic ductal adenocarcinoma. DocWire News recently spoke with Corey Siegel, MD, MS, a gastroenterologist from Dartmouth Hitchcock Medical Center, ... DocWire News recently spoke with Dr. Thomas Lendvay, Co-Founder and Chief Medical Officer of Tend, a company dedicating ... DocWire News: Can you provide us with some professional background on yourself? ... In the pilot study, ORIGAMI, researchers investigated whether direct oral anticoagulants (DOACs) could be safely used to ... Inflammatory bowel disease (IBD) is associated with a 2.5-fold increase of venous thromboembolism (VTE), a 1.2-fold ... Emily Goss was a normal, healthy 23-year-old woman living in Amarillo, Texas, before she required a liver transplant on ... A group of Harvard researchers has recently created a probiotic hydrogel that can function as a Band-Aid-like seal for ... Serum zonulin was found to be upregulated in patients with irritable bowel syndrome (IBS) with levels comparable to ... Use of partial fundoplication for the treatment of gastroesophageal reflux disease (GERD) may be superior for total ... A diet free of gluten could improve symptoms in patients with irritable bowel syndrome (IBS), according to a study ... About one-quarter of patients who underwent intestinal resection for Crohn’s disease experienced postoperative ...